These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 22696822)
1. Complete hydatidiform mole in women aged 40 to 49 years. Elias KM; Shoni M; Bernstein M; Goldstein DP; Berkowitz RS J Reprod Med; 2012; 57(5-6):254-8. PubMed ID: 22696822 [TBL] [Abstract][Full Text] [Related]
2. Complete hydatidiform mole in women older than age 50. Elias KM; Goldstein DP; Berkowitz RS J Reprod Med; 2010; 55(5-6):208-12. PubMed ID: 20626176 [TBL] [Abstract][Full Text] [Related]
3. Hydatidiform mole in Turkey: results from six centers. Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823 [TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling. Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484 [TBL] [Abstract][Full Text] [Related]
5. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study. Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399 [TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828 [TBL] [Abstract][Full Text] [Related]
7. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585 [TBL] [Abstract][Full Text] [Related]
9. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. Zhao P; Chen Q; Lu W BMC Cancer; 2017 Nov; 17(1):733. PubMed ID: 29121880 [TBL] [Abstract][Full Text] [Related]
10. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole. Elmer DB; Granai CO; Ball HG; Curry SL Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320 [TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
12. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia. Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251 [TBL] [Abstract][Full Text] [Related]
13. Persistent trophoblast disease following partial molar pregnancy. Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [TBL] [Abstract][Full Text] [Related]
14. Guidelines following hydatidiform mole: a reappraisal. Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032 [TBL] [Abstract][Full Text] [Related]
15. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study. Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191 [TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909 [TBL] [Abstract][Full Text] [Related]
18. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Kang WD; Choi HS; Kim SM Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931 [TBL] [Abstract][Full Text] [Related]
19. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole]. Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]